Amy Kunchok

2.5k total citations
47 papers, 1.0k citations indexed

About

Amy Kunchok is a scholar working on Neurology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Amy Kunchok has authored 47 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Neurology, 20 papers in Pathology and Forensic Medicine and 11 papers in Rheumatology. Recurrent topics in Amy Kunchok's work include Peripheral Neuropathies and Disorders (24 papers), Autoimmune Neurological Disorders and Treatments (21 papers) and Multiple Sclerosis Research Studies (19 papers). Amy Kunchok is often cited by papers focused on Peripheral Neuropathies and Disorders (24 papers), Autoimmune Neurological Disorders and Treatments (21 papers) and Multiple Sclerosis Research Studies (19 papers). Amy Kunchok collaborates with scholars based in United States, Italy and Thailand. Amy Kunchok's co-authors include Andrew McKeon, Sean J. Pittock, Αναστασία Ζεκερίδου, Eoin P. Flanagan, Brian G. Weinshenker, John J. Chen, Karl N. Krecke, A. Sebastian López‐Chiriboga, Elia Sechi and Nicholas L. Zalewski and has published in prestigious journals such as New England Journal of Medicine, Neurology and Annals of Neurology.

In The Last Decade

Amy Kunchok

40 papers receiving 993 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Kunchok United States 16 807 517 227 137 93 47 1.0k
Leslie Benson United States 12 650 0.8× 585 1.1× 214 0.9× 86 0.6× 58 0.6× 23 964
Masoud Majed United States 11 902 1.1× 858 1.7× 332 1.5× 114 0.8× 91 1.0× 23 1.2k
Mark Woodhall United Kingdom 10 937 1.2× 854 1.7× 346 1.5× 131 1.0× 87 0.9× 14 1.2k
Giulia Fadda Canada 13 449 0.6× 547 1.1× 160 0.7× 96 0.7× 101 1.1× 33 784
Metha Apiwattanakul Thailand 12 651 0.8× 655 1.3× 214 0.9× 110 0.8× 42 0.5× 44 900
Juichi Fujimori Japan 17 763 0.9× 994 1.9× 348 1.5× 185 1.4× 81 0.9× 80 1.2k
Jiraporn Jitprapaikulsan Thailand 15 719 0.9× 741 1.4× 272 1.2× 61 0.4× 69 0.7× 45 945
So‐Young Huh South Korea 23 949 1.2× 899 1.7× 306 1.3× 98 0.7× 236 2.5× 51 1.5k
Alessandro Barilaro Italy 14 292 0.4× 349 0.7× 130 0.6× 125 0.9× 88 0.9× 39 689
Saif Huda United Kingdom 18 795 1.0× 382 0.7× 120 0.5× 80 0.6× 47 0.5× 56 1.0k

Countries citing papers authored by Amy Kunchok

Since Specialization
Citations

This map shows the geographic impact of Amy Kunchok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Kunchok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Kunchok more than expected).

Fields of papers citing papers by Amy Kunchok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Kunchok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Kunchok. The network helps show where Amy Kunchok may publish in the future.

Co-authorship network of co-authors of Amy Kunchok

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Kunchok. A scholar is included among the top collaborators of Amy Kunchok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Kunchok. Amy Kunchok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kunchok, Amy, Moein Amin, Robert Bermel, et al.. (2025). Volumetric MRI Comparing Longitudinal Change in MOGAD to NMOSD , MS and Healthy Controls, and Disability Associations. Annals of Neurology. 98(5). 1044–1056.
2.
Bruijn, Marienke A.A.M. de, Frank Leypoldt, Josep Dalmau, et al.. (2025). Autoimmune encephalitis. Nature Reviews Disease Primers. 11(1). 65–65. 1 indexed citations
3.
Li, Yadi, Alex Milinovich, Justin Abbatemarco, et al.. (2024). Longitudinal Disability, Cognitive Impairment, and Mood Symptoms in Patients With Anti-NMDA Receptor Encephalitis. Neurology. 102(4). e208019–e208019. 12 indexed citations
4.
Cohen, Jeffrey A., et al.. (2024). Review of the Longitudinal Management of Autoimmune Encephalitis, Potential Biomarkers, and Novel Therapeutics. Neurology Clinical Practice. 14(4). e200306–e200306. 5 indexed citations
5.
Li, Yadi, Brittany Lapin, Le H. Hua, et al.. (2024). Inflammatory disease in people with multiple sclerosis treated with immune checkpoint inhibitors. Annals of Clinical and Translational Neurology. 12(3). 643–647.
6.
Li, Yadi, Nicolas R. Thompson, Alex Milinovich, et al.. (2024). Predicting disability and mortality in CV2/CRMP5‐IgG associated paraneoplastic neurologic disorders. Annals of Clinical and Translational Neurology. 11(3). 710–718.
7.
Majed, Masoud, Cristina Valencia-Sánchez, Jeffrey L. Bennett, et al.. (2023). Alterations in Aquaporin‐4‐IgG Serostatus in 986 Patients: A Laboratory‐Based Longitudinal Analysis. Annals of Neurology. 94(4). 727–735. 15 indexed citations
8.
Flanagan, Eoin P., et al.. (2023). Laboratory evaluation for the differential diagnosis of possible multiple sclerosis in the United States: A physician survey. Journal of the Neurological Sciences. 453. 120781–120781. 1 indexed citations
9.
Kim, Ho Jin, Orhan Aktaş, Kristina R. Patterson, et al.. (2023). Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism. Annals of Clinical and Translational Neurology. 10(12). 2413–2420. 8 indexed citations
10.
Li, Yadi, Moein Amin, Brittany Lapin, et al.. (2023). Clinical Determinants of Longitudinal Disability in LGI-1-IgG Autoimmune Encephalitis. Neurology Neuroimmunology & Neuroinflammation. 11(1). 14 indexed citations
11.
Galioto, Rachel, et al.. (2022). Cognitive outcomes in anti-LGI-1 encephalitis. Journal of the International Neuropsychological Society. 29(6). 541–550. 12 indexed citations
12.
Crum, Brian A., Michelle F. Devine, Αναστασία Ζεκερίδου, et al.. (2022). Motor-neuron-disease-like phenotype associated with IgLON5 disease. Journal of Neurology. 269(11). 6139–6144. 13 indexed citations
13.
Sechi, Elia, Karl N. Krecke, Steven A. Messina, et al.. (2021). Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders. Neurology. 97(11). e1097–e1109. 92 indexed citations
14.
Amin, Moein, et al.. (2021). Myelin oligodendrocyte glycoprotein (MOG) antibodies in a patient with glioblastoma: Red flags for false positivity. Journal of Neuroimmunology. 361. 577743–577743. 5 indexed citations
15.
Kunchok, Amy, Andrew McKeon, Αναστασία Ζεκερίδου, et al.. (2021). Autoimmune/Paraneoplastic Encephalitis Antibody Biomarkers: Frequency, Age, and Sex Associations. Mayo Clinic Proceedings. 97(3). 547–559. 36 indexed citations
16.
Toljan, Karlo, Moein Amin, Amy Kunchok, & Daniel Ontaneda. (2021). New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure. Journal of Neuroimmunology. 362. 577785–577785. 36 indexed citations
17.
Banks, Samantha A., Padraig P. Morris, John J. Chen, et al.. (2020). Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS. Journal of Neurology Neurosurgery & Psychiatry. 92(4). 384–390. 76 indexed citations
18.
López‐Chiriboga, A. Sebastian, Marina Buciuc, Elia Sechi, et al.. (2020). Long term outcomes in Myelin Oligodendrocyte Glycoprotein-IgG (MOG-IgG) Associated Disorders (1906). Neurology. 94(15_supplement). 1 indexed citations
19.
Flanagan, Eoin P., Sean J. Pittock, Amy Kunchok, et al.. (2020). Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies. American Journal of Ophthalmology. 220. 110–114. 53 indexed citations
20.
Kunchok, Amy, et al.. (2017). Fatal reversible cerebral vasoconstriction syndrome. Journal of the Neurological Sciences. 385. 146–150. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leslie Benson Breakdown of academic impact, for papers by Masoud Majed Breakdown of academic impact, for papers by Mark Woodhall Breakdown of academic impact, for papers by Giulia Fadda Breakdown of academic impact, for papers by Metha Apiwattanakul Breakdown of academic impact, for papers by Juichi Fujimori Breakdown of academic impact, for papers by Jiraporn Jitprapaikulsan Breakdown of academic impact, for papers by So‐Young Huh Breakdown of academic impact, for papers by Alessandro Barilaro Breakdown of academic impact, for papers by Saif Huda
Rankless by CCL
2026